arXiv:2603.12808cs.LG2026-03

用结构化推理让小模型超越大模型,智能设计药物分子

A Multi-task Large Reasoning Model for Molecular Science

  • 多专家模块+思维链框架,模拟科学家思考过程
  • 10项任务平均提升50.3%,用更少数据超20个顶尖模型
  • 适合药物研发与可解释性要求高的分子智能场景

人工智能在分子科学中的进展正推动范式转变,从纯数据驱动预测转向知识引导的计算推理。现有分子模型大多为专有系统,缺乏通用分子智能与泛化能力。为此,我们提出一种多任务大推理模型,通过结构化推理与反思机制,模拟分子科学家的认知过程。该方法包含多专家模块以提供多样化分子专业知识,并采用强化学习增强的思维链(CoT)框架,融入分子知识,实现结构化与反思性推理。在10个分子任务和47项指标上的系统评估表明,该模型相比基础架构平均提升50.3%,优于超过20个先进基线模型,包括参数量巨大的基础模型,且使用更少训练数据和计算资源。结果验证了显式推理机制可实现高效学习,使小规模模型在效果与可解释性上超越大规模模型。实际案例研究展示了其在中枢神经系统(CNS)药物候选物设计中的应用潜力,证明该框架能有效融合数据驱动与知识集成方法,推动智能分子设计。

原文摘要 · Abstract (English)

Advancements in artificial intelligence for molecular science are necessitating a paradigm shift from purely data-driven predictions to knowledge-guided computational reasoning. Existing molecular models are predominantly proprietary, lacking general molecular intelligence and generalizability. This underscores the necessity for computational methods that can effectively integrate scientific logic with deep learning architectures. Here we introduce a multi-task large reasoning model designed to emulate the cognitive processes of molecular scientists through structured reasoning and reflection. Our approach incorporates multi-specialist modules to provide versatile molecular expertise and a chain-of-thought (CoT) framework enhanced by reinforcement learning infused with molecular knowledge, enabling structured and reflective reasoning. Systematic evaluations across 10 molecular tasks and 47 metrics demonstrate that our model achieves an average 50.3% improvement over the base architecture, outperforming over 20 state-of-the-art baselines, including ultra-large-parameter foundation models, despite using significantly fewer training data and computational resources. This validates that embedding explicit reasoning mechanisms enables high-efficiency learning, allowing smaller-scale models to surpass massive counterparts in both efficacy and interpretability. The practical utility of this computational framework was validated through a case study on the design of central nervous system (CNS) drug candidates, illustrating its capacity to bridge data-driven and knowledge-integrated approaches for intelligent molecular design.

分子生成推理模型药物设计

Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。